| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | microtubule-based process | DNHD1 TPR SDCCAG8 APOB CNTLN STIL PGK2 DNALI1 PHLDB1 CCDC88A CEP250 SYNE2 NAT10 SSX2IP PDE4DIP FBXW5 ASPM MACF1 ROCK1 CEP295 KLC1 JHY PCNT BBOF1 | 2.51e-10 | 1058 | 102 | 24 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | TPR AKAIN1 SYNE1 SPTA1 SDCCAG8 LRSAM1 SPTBN1 STIL LMOD3 PHLDB1 CCDC88A SETD5 LZTS1 FHOD1 SYNE2 PDE4DIP MACF1 ROCK1 CEP295 HSF1 MAP3K7 EP300 PLCE1 | 1.32e-08 | 1189 | 102 | 23 | GO:0044087 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TPR SDCCAG8 CNTLN STIL PHLDB1 CCDC88A CEP250 SYNE2 NAT10 SSX2IP PDE4DIP FBXW5 ASPM ROCK1 CEP295 JHY PCNT BBOF1 | 1.40e-08 | 720 | 102 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | centrosome cycle | 1.24e-07 | 164 | 102 | 9 | GO:0007098 | |
| GeneOntologyBiologicalProcess | organelle assembly | DNHD1 TPR MYH11 SYNE1 SDCCAG8 LRSAM1 WWTR1 STIL DNALI1 LMOD3 CCDC88A CEP250 SYNE2 SSX2IP ASPM CEP295 HSF1 EP300 JHY PCNT BBOF1 | 1.41e-07 | 1138 | 102 | 21 | GO:0070925 |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 2.62e-07 | 179 | 102 | 9 | GO:0031023 | |
| GeneOntologyBiologicalProcess | cilium assembly | DNHD1 SYNE1 SDCCAG8 WWTR1 STIL DNALI1 CCDC88A CEP250 SYNE2 SSX2IP JHY PCNT BBOF1 | 2.94e-07 | 444 | 102 | 13 | GO:0060271 |
| GeneOntologyBiologicalProcess | cilium organization | DNHD1 SYNE1 SDCCAG8 WWTR1 STIL DNALI1 CCDC88A CEP250 SYNE2 SSX2IP JHY PCNT BBOF1 | 6.46e-07 | 476 | 102 | 13 | GO:0044782 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | DNHD1 SYNE1 SDCCAG8 WWTR1 STIL DNALI1 CCDC88A CEP250 SYNE2 SSX2IP ROCK1 JHY PCNT PLCE1 BBOF1 | 1.03e-06 | 670 | 102 | 15 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | DNHD1 SYNE1 SDCCAG8 WWTR1 STIL DNALI1 CCDC88A CEP250 SYNE2 SSX2IP ROCK1 JHY PCNT PLCE1 BBOF1 | 1.36e-06 | 685 | 102 | 15 | GO:0030031 |
| GeneOntologyBiologicalProcess | cell cycle process | CUL3 TPR RAB35 SDCCAG8 SPTBN1 SYCP3 CNTLN STIL TFAP4 CREB3L1 CEP250 NAT10 SSX2IP PDE4DIP FBXW5 ASPM ROCK1 CEP295 HSF1 SYCE1 PCNT | 6.31e-06 | 1441 | 102 | 21 | GO:0022402 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | CUL3 TPR SYNE1 SPTA1 SDCCAG8 LRSAM1 SPTBN1 STIL LMOD3 PHLDB1 CCDC88A FHOD1 SYNE2 NAT10 PDE4DIP FBXW5 ROCK1 CEP295 HSF1 EP300 | 7.86e-06 | 1342 | 102 | 20 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | 1.05e-05 | 280 | 102 | 9 | GO:1902115 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 1.50e-05 | 293 | 102 | 9 | GO:0032886 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex assembly | 2.44e-05 | 173 | 102 | 7 | GO:0031333 | |
| GeneOntologyBiologicalProcess | centrosome localization | 2.62e-05 | 35 | 102 | 4 | GO:0051642 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | TPR SPTA1 SPTBN1 STIL LMOD3 PHLDB1 CCDC88A FHOD1 PDE4DIP ROCK1 CEP295 EP300 | 2.90e-05 | 579 | 102 | 12 | GO:0051493 |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 2.94e-05 | 36 | 102 | 4 | GO:0061842 | |
| GeneOntologyBiologicalProcess | positive regulation by host of viral transcription | 7.59e-05 | 17 | 102 | 3 | GO:0043923 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle assembly | 1.20e-04 | 97 | 102 | 5 | GO:1902117 | |
| GeneOntologyBiologicalProcess | regulation of centrosome duplication | 1.27e-04 | 52 | 102 | 4 | GO:0010824 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | TPR LRSAM1 STIL PHLDB1 CCDC88A FHOD1 PDE4DIP ROCK1 CEP295 HSF1 PLCE1 | 1.44e-04 | 582 | 102 | 11 | GO:0044089 |
| GeneOntologyBiologicalProcess | nuclear matrix organization | 1.44e-04 | 4 | 102 | 2 | GO:0043578 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 1.86e-04 | 239 | 102 | 7 | GO:0031032 | |
| GeneOntologyBiologicalProcess | regulation of centrosome cycle | 2.68e-04 | 63 | 102 | 4 | GO:0046605 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | TPR RAB35 ANGPT1 UACA TNPO2 SYNE1 LRSAM1 WWTR1 CNTLN STIL CCDC88A CEP250 MACF1 EP300 GOLGB1 | 2.98e-04 | 1091 | 102 | 15 | GO:0033365 |
| GeneOntologyBiologicalProcess | spermatogenesis | DNHD1 SYNE1 SPATA20 SYCP3 APOB CNTLN MAST2 DNALI1 ASPM HSF1 GOLGA3 BBOF1 | 3.07e-04 | 744 | 102 | 12 | GO:0007283 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | CUL3 TPR ANGPT1 SYNE1 LRSAM1 STIL PHLDB1 CCDC88A ATP8A1 FHOD1 PDE4DIP MACF1 ROCK1 CEP295 HSF1 EP300 PLCE1 | 3.66e-04 | 1366 | 102 | 17 | GO:0051130 |
| GeneOntologyBiologicalProcess | male gamete generation | DNHD1 SYNE1 SPATA20 SYCP3 APOB CNTLN MAST2 DNALI1 ASPM HSF1 GOLGA3 BBOF1 | 3.81e-04 | 762 | 102 | 12 | GO:0048232 |
| GeneOntologyBiologicalProcess | chromatin organization | TPR SYCP3 CHD1 GATAD2B PRDM2 PWWP2A BPTF RCOR1 KMT2D SETD5 MAP3K7 TCF7L1 EP300 | 4.71e-04 | 896 | 102 | 13 | GO:0006325 |
| GeneOntologyBiologicalProcess | positive regulation of cytoskeleton organization | 5.46e-04 | 205 | 102 | 6 | GO:0051495 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | CUL3 TPR LRSAM1 STIL CCDC88A FHOD1 PDE4DIP CEP295 HSF1 EP300 | 5.53e-04 | 574 | 102 | 10 | GO:0010638 |
| GeneOntologyBiologicalProcess | nuclear migration | 6.29e-04 | 34 | 102 | 3 | GO:0007097 | |
| GeneOntologyBiologicalProcess | regulation of protein import into nucleus | 7.00e-04 | 81 | 102 | 4 | GO:0042306 | |
| GeneOntologyBiologicalProcess | centrosome duplication | 7.00e-04 | 81 | 102 | 4 | GO:0051298 | |
| GeneOntologyCellularComponent | centriole | 1.88e-06 | 172 | 101 | 8 | GO:0005814 | |
| GeneOntologyCellularComponent | microtubule organizing center | CUL3 SDCCAG8 CNTLN STIL CCDC88A CEP250 SSX2IP PDE4DIP ASPM ROCK1 CEP295 HSF1 PCNT BBOF1 | 1.33e-04 | 919 | 101 | 14 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | CUL3 SDCCAG8 CNTLN STIL CCDC88A CEP250 SSX2IP PDE4DIP ASPM CEP295 HSF1 PCNT | 3.39e-04 | 770 | 101 | 12 | GO:0005813 |
| GeneOntologyCellularComponent | ciliary basal body | 3.71e-04 | 195 | 101 | 6 | GO:0036064 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 7.70e-04 | 85 | 101 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 8.14e-04 | 9 | 101 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | spectrin | 8.14e-04 | 9 | 101 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | bleb | 1.01e-03 | 10 | 101 | 2 | GO:0032059 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.24e-03 | 11 | 101 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.24e-03 | 11 | 101 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.24e-03 | 11 | 101 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.24e-03 | 11 | 101 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | cilium | CUL3 DNHD1 SDCCAG8 PGK2 DNALI1 CCDC88A CEP250 SSX2IP CLTB KLC1 PCNT BBOF1 | 1.30e-03 | 898 | 101 | 12 | GO:0005929 |
| GeneOntologyCellularComponent | supramolecular fiber | CUL3 KRT78 MYH11 SYNE1 SPTBN1 LMOD3 KRT77 SYNE2 PDE4DIP ASPM MACF1 CEP295 KLC1 PCNT | 1.58e-03 | 1179 | 101 | 14 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CUL3 KRT78 MYH11 SYNE1 SPTBN1 LMOD3 KRT77 SYNE2 PDE4DIP ASPM MACF1 CEP295 KLC1 PCNT | 1.68e-03 | 1187 | 101 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | cuticular plate | 1.74e-03 | 13 | 101 | 2 | GO:0032437 | |
| HumanPheno | Broad eyebrow | 7.39e-06 | 29 | 50 | 5 | HP:0011229 | |
| HumanPheno | Thin upper lip vermilion | TPR SPTBN1 STIL GATAD2B POLR3A BPTF KMT2D SETD5 CDK13 ASPM CEP295 EP300 DSE | 1.49e-05 | 339 | 50 | 13 | HP:0000219 |
| HumanPheno | Thin lips | TPR SPTBN1 STIL GATAD2B POLR3A BPTF KMT2D SETD5 CDK13 ASPM CEP295 EP300 DSE | 1.49e-05 | 339 | 50 | 13 | HP:0000213 |
| HumanPheno | Upslanted palpebral fissure | SPTBN1 STIL GATAD2B POLR3A BPTF SETD5 CDK13 ASPM CEP295 MAP3K7 EP300 PCNT | 6.31e-05 | 333 | 50 | 12 | HP:0000582 |
| Domain | Spectrin_repeat | 9.81e-09 | 29 | 102 | 6 | IPR002017 | |
| Domain | SPEC | 1.85e-08 | 32 | 102 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.85e-08 | 32 | 102 | 6 | IPR018159 | |
| Domain | Spectrin | 1.37e-07 | 23 | 102 | 5 | PF00435 | |
| Domain | ACTININ_2 | 6.85e-06 | 23 | 102 | 4 | PS00020 | |
| Domain | ACTININ_1 | 6.85e-06 | 23 | 102 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 6.85e-06 | 23 | 102 | 4 | IPR001589 | |
| Domain | CH | 2.80e-05 | 65 | 102 | 5 | SM00033 | |
| Domain | CH | 4.02e-05 | 70 | 102 | 5 | PF00307 | |
| Domain | - | 4.31e-05 | 71 | 102 | 5 | 1.10.418.10 | |
| Domain | CH | 4.92e-05 | 73 | 102 | 5 | PS50021 | |
| Domain | CH-domain | 5.61e-05 | 75 | 102 | 5 | IPR001715 | |
| Domain | KASH | 1.76e-04 | 4 | 102 | 2 | IPR012315 | |
| Domain | KASH | 1.76e-04 | 4 | 102 | 2 | PS51049 | |
| Domain | DUF1908 | 1.76e-04 | 4 | 102 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 1.76e-04 | 4 | 102 | 2 | IPR015022 | |
| Domain | KASH | 1.76e-04 | 4 | 102 | 2 | SM01249 | |
| Domain | KASH | 1.76e-04 | 4 | 102 | 2 | PF10541 | |
| Domain | MAST_pre-PK_dom | 1.76e-04 | 4 | 102 | 2 | IPR023142 | |
| Domain | - | 1.76e-04 | 4 | 102 | 2 | 1.20.1480.20 | |
| Domain | Kinase-like_dom | 7.60e-04 | 542 | 102 | 10 | IPR011009 | |
| Domain | SET | 1.45e-03 | 41 | 102 | 3 | PF00856 | |
| Domain | Pkinase_C | 1.56e-03 | 42 | 102 | 3 | PF00433 | |
| Domain | SET | 2.02e-03 | 46 | 102 | 3 | SM00317 | |
| Domain | ELM2_dom | 2.22e-03 | 13 | 102 | 2 | IPR000949 | |
| Domain | ELM2 | 2.22e-03 | 13 | 102 | 2 | PF01448 | |
| Domain | ELM2 | 2.22e-03 | 13 | 102 | 2 | PS51156 | |
| Domain | ELM2 | 2.22e-03 | 13 | 102 | 2 | SM01189 | |
| Domain | SET_dom | 2.57e-03 | 50 | 102 | 3 | IPR001214 | |
| Domain | SET | 2.57e-03 | 50 | 102 | 3 | PS50280 | |
| Domain | ARM-type_fold | 2.58e-03 | 339 | 102 | 7 | IPR016024 | |
| Domain | Ser/Thr_kinase_AS | 3.44e-03 | 357 | 102 | 7 | IPR008271 | |
| Domain | S_TKc | 3.54e-03 | 359 | 102 | 7 | SM00220 | |
| Domain | AGC-kinase_C | 3.55e-03 | 56 | 102 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.55e-03 | 56 | 102 | 3 | PS51285 | |
| Domain | S_TK_X | 3.55e-03 | 56 | 102 | 3 | SM00133 | |
| Domain | PROTEIN_KINASE_ST | 3.71e-03 | 362 | 102 | 7 | PS00108 | |
| Domain | Fibrinogen_CS | 4.75e-03 | 19 | 102 | 2 | IPR020837 | |
| Domain | Myosin-like_IQ_dom | 4.75e-03 | 19 | 102 | 2 | IPR027401 | |
| Domain | - | 4.75e-03 | 19 | 102 | 2 | 4.10.270.10 | |
| Domain | Pkinase | 4.90e-03 | 381 | 102 | 7 | PF00069 | |
| Pubmed | CUL3 TPR UACA SYNE1 SPTBN1 SPATA20 GATAD2B RCOR1 CCDC88A LZTS1 SYNE2 NAT10 PDE4DIP MACF1 ROCK1 GOLGA3 GOLGB1 KLC1 PCNT | 6.97e-11 | 963 | 104 | 19 | 28671696 | |
| Pubmed | DNHD1 TPR SYNE1 MAST2 IGF2BP3 KMT2D CEP250 NAT10 ASPM MACF1 GOLGB1 | 1.30e-10 | 234 | 104 | 11 | 36243803 | |
| Pubmed | TPR PRDM2 RCOR1 KMT2D CCDC88A FAM193A ZFHX4 ZNF644 RCOR3 GOLGA3 GOLGB1 KLC1 PCNT | 4.13e-10 | 418 | 104 | 13 | 34709266 | |
| Pubmed | ABCF1 UACA SYNE1 COQ5 SPTBN1 CHD1 CCDC88A FAM193A DNAJC28 ZNF644 SYNE2 NAT10 SSX2IP ASPM MACF1 COL14A1 TBL2 GOLGA3 GOLGB1 MAST3 KLC1 PCNT | 4.37e-10 | 1487 | 104 | 22 | 33957083 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CUL3 TPR ABCF1 ERCC5 UACA SPTBN1 TFAP4 GATAD2B PRDM2 BPTF KMT2D CDK13 ZNF644 FHOD1 EIF2B5 HSF1 | 1.34e-09 | 774 | 104 | 16 | 15302935 |
| Pubmed | TPR MYH11 SYNE1 SPTBN1 LAMA3 WWTR1 CCDC88A FHOD1 CEP250 MACF1 MAP3K7 EP300 GOLGB1 | 2.55e-09 | 486 | 104 | 13 | 20936779 | |
| Pubmed | MYH11 ERCC5 SYNE1 SPTA1 SPTBN1 APOB PGK2 BPTF LMOD3 SETD5 CDK13 KRT77 SYNE2 ASPM MACF1 CEP295 OTUD3 GOLGB1 PCNT BBOF1 | 9.10e-09 | 1442 | 104 | 20 | 35575683 | |
| Pubmed | TPR ERCC5 BMP2K SPTBN1 APOB PRDM2 RCOR1 SETD5 NAT10 MACF1 ROCK1 RCOR3 CEP295 POLK DSE GOLGB1 PCNT | 2.34e-08 | 1084 | 104 | 17 | 11544199 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 33472039 | ||
| Pubmed | UACA GIGYF1 REV3L MAST2 GATAD2B BPTF RCOR1 ZFHX4 SETD5 NAT10 SSX2IP ASPM MACF1 RCOR3 CEP295 TCF7L1 EP300 | 3.57e-08 | 1116 | 104 | 17 | 31753913 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR RAB35 KRT78 ABCF1 SYNE1 CHD1 BPTF IGF2BP3 PHLDB1 KRT77 SYNE2 NAT10 MACF1 SNRPD2 GOLGB1 PCNT | 6.67e-08 | 1024 | 104 | 16 | 24711643 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 7.86e-08 | 120 | 104 | 7 | 31413325 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KRT78 SPTBN1 WWTR1 GIGYF1 STIL MAST2 PHLDB1 CCDC88A KRT77 SYNE2 SSX2IP MACF1 GOLGB1 KLC1 | 2.96e-07 | 861 | 104 | 14 | 36931259 |
| Pubmed | UACA SYNE1 SPTBN1 MAST2 SYNE2 PDE4DIP MACF1 COL14A1 RCOR3 MAP3K7 PLCE1 | 3.07e-07 | 497 | 104 | 11 | 23414517 | |
| Pubmed | 3.95e-07 | 152 | 104 | 7 | 34299191 | ||
| Pubmed | CUL3 SYNE1 SPTBN1 APOB IGF2BP3 PHLDB1 SYNE2 NAT10 HSF1 SNRPD2 EP300 GOLGA3 GOLGB1 | 4.22e-07 | 754 | 104 | 13 | 35906200 | |
| Pubmed | 6.22e-07 | 101 | 104 | 6 | 26949739 | ||
| Pubmed | 8.92e-07 | 340 | 104 | 9 | 29478914 | ||
| Pubmed | CUL3 ABCF1 TNPO2 TFAP4 GATAD2B PRDM2 BPTF RCOR1 IGF2BP3 KMT2D CDK13 ZNF644 CLTB SNRPD2 EP300 | 1.03e-06 | 1103 | 104 | 15 | 34189442 | |
| Pubmed | TNPO2 SPTBN1 GIGYF1 TFAP4 GATAD2B PRDM2 BPTF RCOR1 IGF2BP3 KMT2D ZFHX4 ZNF644 SYNE2 NAT10 RCOR3 SNRPD2 EP300 | 1.15e-06 | 1429 | 104 | 17 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.16e-06 | 351 | 104 | 9 | 38297188 | |
| Pubmed | 1.26e-06 | 27 | 104 | 4 | 18685082 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SPTA1 WWTR1 TFAP4 GATAD2B PRDM2 PWWP2A BPTF RCOR1 KMT2D CDK13 ZNF644 NAT10 RCOR3 SNRPD2 TBL2 EP300 | 1.50e-06 | 1294 | 104 | 16 | 30804502 |
| Pubmed | 1.55e-06 | 118 | 104 | 6 | 30979931 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | LRSAM1 CNTLN IGF2BP3 CCDC88A ZNF644 ASPM MACF1 ROCK1 POLK GOLGB1 PCNT | 1.59e-06 | 588 | 104 | 11 | 38580884 |
| Pubmed | 1.59e-06 | 187 | 104 | 7 | 26460568 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CUL3 ABCF1 BMP2K SDCCAG8 CNTLN STIL MAST2 CCDC88A CEP250 SSX2IP CEP295 KLC1 PCNT | 1.66e-06 | 853 | 104 | 13 | 28718761 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CUL3 ABCF1 SDCCAG8 ZYG11B GIGYF1 DNALI1 RCOR1 CCDC88A SETD5 CLTB EIF2B5 COL14A1 HSF1 SNRPD2 MAST3 KLC1 | 1.96e-06 | 1321 | 104 | 16 | 27173435 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | BMP2K SYNE1 COQ5 POLR3A IGF2BP3 DNAJC28 CDK13 KRT77 ZNF644 SYNE2 NAT10 SSX2IP MAP3K7 TBL2 GOLGA3 GOLGB1 PCNT | 2.14e-06 | 1496 | 104 | 17 | 32877691 |
| Pubmed | MYH11 ANGPT1 UACA GATAD2B PWWP2A CDK13 TMCC2 SSX2IP MACF1 MAST3 | 2.38e-06 | 493 | 104 | 10 | 15368895 | |
| Pubmed | 2.40e-06 | 285 | 104 | 8 | 32838362 | ||
| Pubmed | A B-Myb complex containing clathrin and filamin is required for mitotic spindle function. | 3.07e-06 | 10 | 104 | 3 | 18548008 | |
| Pubmed | Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle. | 3.07e-06 | 10 | 104 | 3 | 28533284 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ABCF1 ERCC5 UACA BMP2K CHD1 GATAD2B CDK13 NRK PDE4DIP MAP3K7 EP300 MAST3 KLC1 | 3.37e-06 | 910 | 104 | 13 | 36736316 |
| Pubmed | 3.89e-06 | 407 | 104 | 9 | 12693553 | ||
| Pubmed | 4.21e-06 | 11 | 104 | 3 | 22826121 | ||
| Pubmed | 5.24e-06 | 83 | 104 | 5 | 28794006 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPR MYH11 ABCF1 UACA BMP2K SYNE1 SPTBN1 APOB IGF2BP3 CDK13 NAT10 CLTB SNRPD2 | 5.31e-06 | 949 | 104 | 13 | 36574265 |
| Pubmed | 5.34e-06 | 146 | 104 | 6 | 21399614 | ||
| Pubmed | 5.39e-06 | 225 | 104 | 7 | 12168954 | ||
| Pubmed | TPR ABCF1 SPTBN1 IGF2BP3 CCDC88A KRT77 NAT10 ROCK1 MAP3K7 GOLGA3 | 6.33e-06 | 551 | 104 | 10 | 34728620 | |
| Pubmed | 6.48e-06 | 151 | 104 | 6 | 17043677 | ||
| Pubmed | CUL3 ZYG11B GIGYF1 MAST2 RCOR1 SSX2IP PDE4DIP EIF2B5 ROCK1 RCOR3 SNRPD2 | 7.17e-06 | 689 | 104 | 11 | 36543142 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 33846123 | ||
| Pubmed | Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer. | 8.86e-06 | 2 | 104 | 2 | 25770290 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 11792814 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 8.86e-06 | 2 | 104 | 2 | 24931616 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 24581496 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 28104499 | ||
| Pubmed | Coding variants in the PCNT and CEP295 genes contribute to breast cancer risk in Chinese women. | 8.86e-06 | 2 | 104 | 2 | 34418690 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 18239683 | ||
| Pubmed | Functional analyses of Pericentrin and Syne-2 interaction in ciliogenesis. | 8.86e-06 | 2 | 104 | 2 | 30054381 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 29703820 | ||
| Pubmed | FHOD1 interaction with nesprin-2G mediates TAN line formation and nuclear movement. | 8.86e-06 | 2 | 104 | 2 | 24880667 | |
| Pubmed | Lack of centrioles and primary cilia in STIL(-/-) mouse embryos. | 8.86e-06 | 2 | 104 | 2 | 25486474 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22768332 | ||
| Pubmed | HSF1-TPR interaction facilitates export of stress-induced HSP70 mRNA. | 8.86e-06 | 2 | 104 | 2 | 17897941 | |
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 8.86e-06 | 2 | 104 | 2 | 17267447 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 8.86e-06 | 2 | 104 | 2 | 24718612 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 24586179 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 17761684 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 17905835 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 31578382 | ||
| Pubmed | Investigation of primary microcephaly in Bushehr province of Iran: novel STIL and ASPM mutations. | 8.86e-06 | 2 | 104 | 2 | 22989186 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | UACA SDCCAG8 LAMA3 TFAP4 PCNX2 BPTF PHLDB1 SETD5 CDK13 NAT10 MACF1 RCOR3 POLK EP300 GOLGB1 PCNT | 8.90e-06 | 1489 | 104 | 16 | 28611215 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPR MYH11 SPTBN1 PGK2 POLR3A IGF2BP3 CEP250 MACF1 ROCK1 SNRPD2 GOLGB1 PCNT | 8.97e-06 | 847 | 104 | 12 | 35235311 |
| Pubmed | 1.32e-05 | 360 | 104 | 8 | 33111431 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.35e-05 | 361 | 104 | 8 | 26167880 | |
| Pubmed | Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. | 1.41e-05 | 16 | 104 | 3 | 16096065 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | TPR KRT78 ABCF1 SPTBN1 GATAD2B IGF2BP3 ZFHX4 KRT77 NAT10 SNRPD2 | 1.42e-05 | 605 | 104 | 10 | 28977666 |
| Pubmed | 1.44e-05 | 102 | 104 | 5 | 11214970 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CUL3 ABCF1 BPTF IGF2BP3 CDK13 NAT10 EIF2B5 ASPM MACF1 SNRPD2 TBL2 | 1.76e-05 | 759 | 104 | 11 | 35915203 |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 1.85e-05 | 495 | 104 | 9 | 27705803 | |
| Pubmed | CUL3 KRT78 MYH11 ABCF1 SYNE1 SPTA1 SPTBN1 PHLDB1 ATP8A1 LZTS1 PDE4DIP MACF1 SNRPD2 GOLGA3 KLC1 | 2.33e-05 | 1431 | 104 | 15 | 37142655 | |
| Pubmed | CUL3 ZNF226 PWWP2A RCOR1 IGF2BP3 SSX2IP ROCK1 MAP3K7 EP300 PCNT | 2.45e-05 | 645 | 104 | 10 | 25281560 | |
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 2.46e-05 | 56 | 104 | 4 | 9455484 | |
| Pubmed | CUL3 RAB35 ABCF1 GIGYF1 MAST2 POLR3A CCDC88A CDK13 EIF2B5 PLCE1 | 2.62e-05 | 650 | 104 | 10 | 38777146 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 18694941 | ||
| Pubmed | Translesion synthesis of 6-nitrochrysene-derived 2'-deoxyadenosine adduct in human cells. | 2.65e-05 | 3 | 104 | 2 | 32721818 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 18657505 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 37410700 | ||
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 2.65e-05 | 3 | 104 | 2 | 16079285 | |
| Pubmed | IMP3 Stabilization of WNT5B mRNA Facilitates TAZ Activation in Breast Cancer. | 2.65e-05 | 3 | 104 | 2 | 29847788 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 30631061 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 10878022 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 12408964 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 17462627 | ||
| Pubmed | Lamins and nesprin-1 mediate inside-out mechanical coupling in muscle cell precursors through FHOD1. | 2.65e-05 | 3 | 104 | 2 | 28455503 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 32207633 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 28732206 | ||
| Pubmed | Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells. | 2.65e-05 | 3 | 104 | 2 | 25516977 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.71e-05 | 398 | 104 | 8 | 35016035 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 2.72e-05 | 289 | 104 | 7 | 23752268 | |
| Pubmed | 2.72e-05 | 653 | 104 | 10 | 22586326 | ||
| Pubmed | 2.76e-05 | 399 | 104 | 8 | 37536630 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.93e-05 | 197 | 104 | 6 | 20811636 | |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 3.02e-05 | 119 | 104 | 5 | 35776542 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 3.30e-05 | 533 | 104 | 9 | 30554943 | |
| Pubmed | 3.84e-05 | 22 | 104 | 3 | 21690297 | ||
| Pubmed | 4.03e-05 | 421 | 104 | 8 | 36976175 | ||
| Interaction | HDAC1 interactions | CUL3 TPR TNPO2 CHD1 TFAP4 GATAD2B POLR3A PWWP2A BPTF RCOR1 KMT2D ZFHX4 CEP250 SYNE2 RCOR3 HSF1 SNRPD2 EP300 GOLGA3 GOLGB1 KLC1 PCNT | 2.75e-08 | 1108 | 102 | 22 | int:HDAC1 |
| Interaction | YWHAZ interactions | CUL3 KRT78 MYH11 UACA SPTA1 SPTBN1 WWTR1 GIGYF1 ITGA2B MAST2 PHLDB1 CCDC88A KRT77 ZNF644 FHOD1 SYNE2 SSX2IP MACF1 HSF1 EP300 GOLGA3 MAST3 KLC1 PCNT | 3.01e-08 | 1319 | 102 | 24 | int:YWHAZ |
| Interaction | KDM1A interactions | CUL3 TPR TNPO2 PRDM2 RCOR1 KMT2D CCDC88A FAM193A ZFHX4 LZTS1 ZNF644 SSX2IP PDE4DIP RCOR3 HSF1 EP300 GOLGA3 GOLGB1 KLC1 PCNT | 4.35e-08 | 941 | 102 | 20 | int:KDM1A |
| Interaction | NDC80 interactions | KRT78 UACA CNTLN CEP250 SYNE2 SSX2IP ASPM ROCK1 CEP295 GOLGA3 SYCE1 PCNT | 5.98e-08 | 312 | 102 | 12 | int:NDC80 |
| Interaction | KAT5 interactions | CUL3 TPR SPTBN1 GIGYF1 LZTS1 TMCC2 ANGPTL4 SSX2IP HSF1 SNRPD2 EP300 SYCE1 | 2.65e-07 | 358 | 102 | 12 | int:KAT5 |
| Interaction | LZTS2 interactions | TPR RAB35 WWTR1 GIGYF1 STIL CCDC88A LZTS1 ZNF644 CEP250 SSX2IP ASPM RCOR3 CEP295 MAP3K7 | 3.00e-07 | 512 | 102 | 14 | int:LZTS2 |
| Interaction | CROCC interactions | 5.25e-07 | 59 | 102 | 6 | int:CROCC | |
| Interaction | YWHAH interactions | CUL3 KRT78 MYH11 UACA SPTBN1 WWTR1 GIGYF1 STIL MAST2 PHLDB1 CCDC88A KRT77 SYNE2 SSX2IP MACF1 MAP3K7 SNRPD2 MAST3 KLC1 PCNT | 5.51e-07 | 1102 | 102 | 20 | int:YWHAH |
| Interaction | FBXO42 interactions | CNTLN IGF2BP3 CCDC88A ZNF644 ASPM MACF1 ROCK1 MAP3K7 GOLGB1 PCNT | 7.80e-07 | 259 | 102 | 10 | int:FBXO42 |
| Interaction | YWHAE interactions | CUL3 MYH11 WWTR1 GIGYF1 ITGA2B CNTLN MAST2 IGF2BP3 PHLDB1 CCDC88A CDK13 KRT77 CEP250 SSX2IP MACF1 ROCK1 HSF1 MAP3K7 GOLGA3 MAST3 KLC1 | 1.04e-06 | 1256 | 102 | 21 | int:YWHAE |
| Interaction | CEP135 interactions | GIGYF1 CNTLN STIL RCOR1 CCDC88A CEP250 SSX2IP CEP295 GOLGB1 PCNT | 1.22e-06 | 272 | 102 | 10 | int:CEP135 |
| Interaction | PHF21A interactions | TPR RCOR1 KMT2D CCDC88A FAM193A ZFHX4 RCOR3 GOLGA3 GOLGB1 KLC1 PCNT | 1.33e-06 | 343 | 102 | 11 | int:PHF21A |
| Interaction | MTA3 interactions | 2.77e-06 | 173 | 102 | 8 | int:MTA3 | |
| Interaction | TLX1 interactions | 3.02e-06 | 175 | 102 | 8 | int:TLX1 | |
| Interaction | TEAD1 interactions | 3.15e-06 | 176 | 102 | 8 | int:TEAD1 | |
| Interaction | NINL interactions | ABCF1 BMP2K SDCCAG8 LRSAM1 GIGYF1 CNTLN STIL RCOR1 CEP250 RCOR3 CEP295 PCNT | 3.49e-06 | 458 | 102 | 12 | int:NINL |
| Interaction | TNIK interactions | TPR SYNE1 SPTBN1 GATAD2B RCOR1 LZTS1 SYNE2 NAT10 PDE4DIP MACF1 MAP3K7 | 3.65e-06 | 381 | 102 | 11 | int:TNIK |
| Interaction | AMOT interactions | CUL3 RAB35 WWTR1 RCOR1 FAM193A LZTS1 CEP250 SSX2IP EP300 PCNT | 4.15e-06 | 312 | 102 | 10 | int:AMOT |
| Interaction | DYRK1A interactions | CUL3 TPR MYH11 ERCC5 SPTBN1 IGF2BP3 KMT2D LZTS1 CLTB EIF2B5 EP300 GOLGB1 PCNT | 4.28e-06 | 552 | 102 | 13 | int:DYRK1A |
| Interaction | CDC16 interactions | 4.44e-06 | 246 | 102 | 9 | int:CDC16 | |
| Interaction | APC interactions | TPR RAB35 MYH11 SYNE1 SPTBN1 LAMA3 STIL RCOR1 FHOD1 CEP250 MACF1 | 4.45e-06 | 389 | 102 | 11 | int:APC |
| Interaction | CHD4 interactions | CUL3 TPR KRT78 ABCF1 GATAD2B PWWP2A BPTF RCOR1 ZFHX4 KRT77 ZNF644 NAT10 HSF1 SNRPD2 EP300 GOLGA3 PCNT | 4.50e-06 | 938 | 102 | 17 | int:CHD4 |
| Interaction | MYH9 interactions | CUL3 MYH11 UACA BMP2K SPTBN1 APOB RCOR1 CEP250 CLTB MACF1 OTUD3 SNRPD2 EP300 GOLGA3 KLC1 | 5.80e-06 | 754 | 102 | 15 | int:MYH9 |
| Interaction | CHD3 interactions | TPR KRT78 SPTBN1 GATAD2B PWWP2A BPTF RCOR1 IGF2BP3 ZFHX4 KRT77 NAT10 HSF1 SNRPD2 EP300 PCNT | 6.08e-06 | 757 | 102 | 15 | int:CHD3 |
| Interaction | HDAC2 interactions | CUL3 KRT78 BMP2K TFAP4 GATAD2B POLR3A PWWP2A BPTF RCOR1 IGF2BP3 ZNF644 ROCK1 COL14A1 RCOR3 HSF1 EP300 | 6.89e-06 | 865 | 102 | 16 | int:HDAC2 |
| Interaction | USP7 interactions | CUL3 DNHD1 TPR SYNE1 SPTBN1 WWTR1 CNTLN STIL MAST2 IGF2BP3 KMT2D CEP250 NAT10 CLTB ASPM MACF1 HSF1 EP300 GOLGB1 KLC1 | 8.01e-06 | 1313 | 102 | 20 | int:USP7 |
| Interaction | YWHAQ interactions | CUL3 TPR MYH11 UACA SPTA1 WWTR1 GIGYF1 MAST2 IGF2BP3 PHLDB1 CCDC88A CEP250 SSX2IP MACF1 RCOR3 HSF1 GOLGB1 KLC1 | 1.16e-05 | 1118 | 102 | 18 | int:YWHAQ |
| Interaction | TNRC6A interactions | 1.26e-05 | 280 | 102 | 9 | int:TNRC6A | |
| Interaction | MTA2 interactions | CUL3 WWTR1 GATAD2B PWWP2A BPTF RCOR1 OTUD3 HSF1 EP300 GOLGA3 PCNT | 1.28e-05 | 435 | 102 | 11 | int:MTA2 |
| Interaction | CEBPA interactions | CUL3 ABCF1 TNPO2 SPTBN1 CHD1 TFAP4 GATAD2B PRDM2 BPTF RCOR1 IGF2BP3 KMT2D CDK13 ZNF644 NAT10 CLTB MACF1 SNRPD2 EP300 | 1.37e-05 | 1245 | 102 | 19 | int:CEBPA |
| Interaction | LATS1 interactions | CUL3 RAB35 KRT78 SPTBN1 WWTR1 MAST2 CCDC88A FAM193A SSX2IP FBXW5 PCNT | 1.42e-05 | 440 | 102 | 11 | int:LATS1 |
| Interaction | KLF3 interactions | 2.09e-05 | 228 | 102 | 8 | int:KLF3 | |
| Interaction | SUZ12 interactions | TNPO2 SYNE1 CHD1 GATAD2B PWWP2A BPTF RCOR1 KMT2D NAT10 RCOR3 SNRPD2 TBL2 PCNT | 2.21e-05 | 644 | 102 | 13 | int:SUZ12 |
| Interaction | GARRE1 interactions | 2.26e-05 | 167 | 102 | 7 | int:GARRE1 | |
| Interaction | SYNC interactions | 2.27e-05 | 67 | 102 | 5 | int:SYNC | |
| Interaction | SOX2 interactions | SPTBN1 LAMA3 CNTLN MAST2 TFAP4 GATAD2B BPTF RCOR1 KMT2D ZFHX4 LZTS1 ZNF644 NAT10 SSX2IP MACF1 RCOR3 SNRPD2 TBL2 EP300 PCNT | 2.56e-05 | 1422 | 102 | 20 | int:SOX2 |
| Interaction | TBXT interactions | 2.74e-05 | 116 | 102 | 6 | int:TBXT | |
| Interaction | FAM193A interactions | 3.01e-05 | 71 | 102 | 5 | int:FAM193A | |
| Interaction | TNIP1 interactions | TPR MYH11 ABCF1 UACA BMP2K SYNE1 SPTBN1 WWTR1 APOB STIL PGK2 RCOR1 IGF2BP3 CDK13 NAT10 SSX2IP CLTB SNRPD2 | 3.60e-05 | 1217 | 102 | 18 | int:TNIP1 |
| Interaction | PAX7 interactions | 4.00e-05 | 124 | 102 | 6 | int:PAX7 | |
| Interaction | GOLGA1 interactions | 4.05e-05 | 183 | 102 | 7 | int:GOLGA1 | |
| Interaction | RCOR1 interactions | CUL3 TPR TNPO2 RCOR1 KMT2D CCDC88A FAM193A ZFHX4 RCOR3 GOLGA3 KLC1 | 4.10e-05 | 494 | 102 | 11 | int:RCOR1 |
| Interaction | MAD2L1 interactions | 4.26e-05 | 252 | 102 | 8 | int:MAD2L1 | |
| Interaction | GAN interactions | 4.38e-05 | 253 | 102 | 8 | int:GAN | |
| Interaction | H3C1 interactions | TPR SYNE1 CHD1 GATAD2B PRDM2 BPTF RCOR1 KMT2D CDK13 ZNF644 NAT10 HSF1 SNRPD2 EP300 JHY | 4.66e-05 | 901 | 102 | 15 | int:H3C1 |
| Interaction | HERC2 interactions | ABCF1 SPTBN1 KMT2D CCDC88A DNAJC28 CEP250 SYNE2 NAT10 SSX2IP ASPM MACF1 | 4.83e-05 | 503 | 102 | 11 | int:HERC2 |
| Interaction | FHL1 interactions | 4.99e-05 | 129 | 102 | 6 | int:FHL1 | |
| Interaction | NRAS interactions | UACA SPTA1 SPTBN1 IGF2BP3 PHLDB1 CCDC88A PIK3CG FHOD1 MACF1 ROCK1 TBL2 GOLGB1 PLCE1 | 5.14e-05 | 699 | 102 | 13 | int:NRAS |
| Interaction | STIL interactions | 5.14e-05 | 190 | 102 | 7 | int:STIL | |
| Interaction | HNF1B interactions | 5.14e-05 | 190 | 102 | 7 | int:HNF1B | |
| Interaction | NADK interactions | 5.35e-05 | 80 | 102 | 5 | int:NADK | |
| Interaction | MAPRE1 interactions | RAB35 SPTBN1 CCDC88A CEP250 SSX2IP PDE4DIP CLTB MACF1 SNRPD2 EP300 PCNT | 5.87e-05 | 514 | 102 | 11 | int:MAPRE1 |
| Interaction | TRIM52 interactions | 5.91e-05 | 133 | 102 | 6 | int:TRIM52 | |
| Interaction | APEX1 interactions | ERCC5 UACA BMP2K SPTBN1 SPATA20 WWTR1 TFAP4 PRDM2 BPTF FAM193A CDK13 ZNF644 NAT10 EIF2B5 POLK MAP3K7 EP300 KLC1 | 6.34e-05 | 1271 | 102 | 18 | int:APEX1 |
| Interaction | PRKACA interactions | CUL3 TPR SPTBN1 ITGA2B LMOD3 IGF2BP3 CCDC88A KRT77 PDE4DIP MAST3 PCNT | 6.40e-05 | 519 | 102 | 11 | int:PRKACA |
| Interaction | BPTF interactions | 6.47e-05 | 197 | 102 | 7 | int:BPTF | |
| Interaction | PHIP interactions | 6.47e-05 | 197 | 102 | 7 | int:PHIP | |
| Interaction | PLEC interactions | CUL3 KRT78 BMP2K SPTA1 RCOR1 CCDC88A SYNE2 PDE4DIP MACF1 PCNT | 6.53e-05 | 430 | 102 | 10 | int:PLEC |
| Interaction | PCM1 interactions | 7.05e-05 | 434 | 102 | 10 | int:PCM1 | |
| Interaction | UHRF2 interactions | 7.11e-05 | 200 | 102 | 7 | int:UHRF2 | |
| Interaction | USF1 interactions | 7.16e-05 | 85 | 102 | 5 | int:USF1 | |
| Interaction | HRAS interactions | CUL3 TPR UACA SPTA1 LRSAM1 SPTBN1 APOB PHLDB1 PIK3CG NRK ROCK1 OTUD3 PLCE1 | 7.45e-05 | 725 | 102 | 13 | int:HRAS |
| Interaction | KIF20A interactions | CUL3 MYH11 ABCF1 UACA SYNE1 SPTBN1 CHD1 APOB PCNX2 IGF2BP3 LZTS1 PIK3CG SYNE2 NAT10 EIF2B5 MACF1 | 7.46e-05 | 1052 | 102 | 16 | int:KIF20A |
| Interaction | NUP43 interactions | ERCC5 CHD1 CCDC168 PRDM2 BPTF KMT2D CCDC88A ATP8A1 ZNF644 CEP250 SYNE2 EIF2B5 | 7.55e-05 | 625 | 102 | 12 | int:NUP43 |
| Interaction | DPY30 interactions | 8.05e-05 | 204 | 102 | 7 | int:DPY30 | |
| Interaction | CUL7 interactions | CUL3 TPR CHD1 APOB BPTF IGF2BP3 CEP250 SYNE2 NAT10 FBXW5 MACF1 SNRPD2 GOLGA3 GOLGB1 | 9.00e-05 | 845 | 102 | 14 | int:CUL7 |
| Interaction | H3-4 interactions | 9.17e-05 | 448 | 102 | 10 | int:H3-4 | |
| Interaction | TNRC6B interactions | 9.37e-05 | 282 | 102 | 8 | int:TNRC6B | |
| Interaction | KRT31 interactions | 1.00e-04 | 453 | 102 | 10 | int:KRT31 | |
| Interaction | PAX6 interactions | 1.01e-04 | 366 | 102 | 9 | int:PAX6 | |
| Interaction | CDC5L interactions | CUL3 TPR ERCC5 SYNE1 SPTBN1 WWTR1 FHOD1 NAT10 PDE4DIP MACF1 SNRPD2 EP300 GOLGB1 PCNT | 1.02e-04 | 855 | 102 | 14 | int:CDC5L |
| Interaction | ARRB2 interactions | CUL3 SPTBN1 ITGA2B TFAP4 RCOR1 CDK13 SYNE2 CLTB MAP3K7 SNRPD2 | 1.02e-04 | 454 | 102 | 10 | int:ARRB2 |
| Interaction | SIN3B interactions | 1.03e-04 | 147 | 102 | 6 | int:SIN3B | |
| Interaction | H3-3A interactions | CUL3 RAB35 CHD1 ZNF226 GATAD2B PRDM2 PWWP2A BPTF KMT2D ZNF644 NAT10 POLK EP300 | 1.03e-04 | 749 | 102 | 13 | int:H3-3A |
| Interaction | RAD50 interactions | 1.12e-04 | 371 | 102 | 9 | int:RAD50 | |
| Interaction | ZNF383 interactions | 1.15e-04 | 19 | 102 | 3 | int:ZNF383 | |
| Interaction | AP2B1 interactions | 1.17e-04 | 373 | 102 | 9 | int:AP2B1 | |
| Interaction | SMARCA4 interactions | CUL3 SPTA1 WWTR1 GATAD2B POLR3A BPTF RCOR1 ANGPTL4 HSF1 EP300 | 1.18e-04 | 462 | 102 | 10 | int:SMARCA4 |
| Interaction | CCDC8 interactions | TPR RAB35 KRT78 ABCF1 APOB IGF2BP3 PHLDB1 KRT77 CEP250 MACF1 GOLGB1 PCNT | 1.19e-04 | 656 | 102 | 12 | int:CCDC8 |
| Interaction | GSK3A interactions | LRSAM1 IGF2BP3 CCDC88A FAM193A SSX2IP EIF2B5 MACF1 HSF1 TBL2 GOLGA3 | 1.22e-04 | 464 | 102 | 10 | int:GSK3A |
| Interaction | MBD3 interactions | 1.28e-04 | 295 | 102 | 8 | int:MBD3 | |
| Interaction | NUMA1 interactions | 1.33e-04 | 469 | 102 | 10 | int:NUMA1 | |
| Interaction | FBXW11 interactions | SPATA20 CHD1 WWTR1 STIL MAST2 TFAP4 ZNF644 NAT10 MAP3K7 MAST3 | 1.43e-04 | 473 | 102 | 10 | int:FBXW11 |
| Interaction | BTRC interactions | TPR SPATA20 CHD1 WWTR1 STIL MAST2 TFAP4 IGF2BP3 SSX2IP HSF1 MAP3K7 EP300 MAST3 | 1.45e-04 | 775 | 102 | 13 | int:BTRC |
| Interaction | FOXK2 interactions | 1.48e-04 | 225 | 102 | 7 | int:FOXK2 | |
| Interaction | EDC4 interactions | 1.52e-04 | 226 | 102 | 7 | int:EDC4 | |
| Interaction | CHAF1B interactions | 1.53e-04 | 158 | 102 | 6 | int:CHAF1B | |
| Interaction | EDC3 interactions | 1.69e-04 | 161 | 102 | 6 | int:EDC3 | |
| Interaction | SKAP1 interactions | 1.70e-04 | 102 | 102 | 5 | int:SKAP1 | |
| Interaction | LGMN interactions | 1.73e-04 | 55 | 102 | 4 | int:LGMN | |
| Interaction | PLEKHA5 interactions | 1.74e-04 | 231 | 102 | 7 | int:PLEKHA5 | |
| Interaction | MYBL2 interactions | 1.75e-04 | 162 | 102 | 6 | int:MYBL2 | |
| Interaction | CFAP184 interactions | 1.75e-04 | 162 | 102 | 6 | int:CFAP184 | |
| Interaction | DCPS interactions | 1.76e-04 | 394 | 102 | 9 | int:DCPS | |
| Interaction | CNTNAP4 interactions | 1.81e-04 | 22 | 102 | 3 | int:CNTNAP4 | |
| Interaction | ANK1 interactions | 1.86e-04 | 56 | 102 | 4 | int:ANK1 | |
| Interaction | NMT1 interactions | 1.94e-04 | 165 | 102 | 6 | int:NMT1 | |
| Interaction | SUMO2 interactions | CUL3 TPR ABCF1 SPTBN1 MAST2 GATAD2B BPTF RCOR1 NAT10 RCOR3 EP300 | 2.00e-04 | 591 | 102 | 11 | int:SUMO2 |
| Interaction | PCNT interactions | 2.26e-04 | 241 | 102 | 7 | int:PCNT | |
| Interaction | ZNF124 interactions | 2.27e-04 | 59 | 102 | 4 | int:ZNF124 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 6.47e-05 | 4 | 60 | 2 | 1252 | |
| GeneFamily | EF-hand domain containing|Spectrins | 2.25e-04 | 7 | 60 | 2 | 1113 | |
| GeneFamily | DNA polymerases | 2.62e-03 | 23 | 60 | 2 | 535 | |
| GeneFamily | Fibrinogen C domain containing | 3.09e-03 | 25 | 60 | 2 | 554 | |
| GeneFamily | Keratins, type II | 3.60e-03 | 27 | 60 | 2 | 609 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | BMP2K CHD1 WWTR1 STIL REV3L MAST2 BPTF RCOR1 IGF2BP3 FAM193A CDK13 SYNE2 MACF1 ROCK1 KLC1 PCNT PLCE1 | 3.87e-08 | 856 | 103 | 17 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CUL3 TPR SYNE1 CHD1 REV3L GATAD2B PRDM2 PCNX2 BPTF KMT2D CCDC88A ATP8A1 SETD5 CDK13 ZNF644 FHOD1 PDE4DIP MACF1 ROCK1 EP300 MAST3 KLC1 | 6.31e-08 | 1492 | 103 | 22 | M40023 |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN | 9.48e-08 | 199 | 103 | 9 | M8259 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 7.29e-06 | 180 | 103 | 7 | M8239 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | ABCF1 ANGPT1 UACA SDCCAG8 SPTBN1 CHD1 WWTR1 MAST2 CEP250 FBXW5 POLK | 4.80e-05 | 646 | 103 | 11 | M2419 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | TPR SPTBN1 SPATA20 WWTR1 REV3L FAM193A LZTS1 SYNE2 NAT10 PDE4DIP MACF1 TBL2 | 6.43e-05 | 790 | 103 | 12 | M12490 |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 6.57e-05 | 107 | 103 | 5 | MM947 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | ABCF1 ANGPT1 UACA SDCCAG8 SPTBN1 CHD1 WWTR1 MAST2 CEP250 FBXW5 POLK | 7.10e-05 | 675 | 103 | 11 | MM1073 |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 7.18e-05 | 109 | 103 | 5 | M2451 | |
| Coexpression | SENESE_HDAC1_TARGETS_UP | 7.34e-05 | 451 | 103 | 9 | M14973 | |
| Coexpression | GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN | 1.34e-04 | 198 | 103 | 6 | M5448 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN | 1.38e-04 | 199 | 103 | 6 | M8031 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.38e-04 | 199 | 103 | 6 | M5893 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 1.38e-04 | 199 | 103 | 6 | M7259 | |
| Coexpression | GSE7852_TREG_VS_TCONV_THYMUS_DN | 1.38e-04 | 199 | 103 | 6 | M5732 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_BCELL_DN | 1.42e-04 | 200 | 103 | 6 | M8261 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN | 1.42e-04 | 200 | 103 | 6 | M4979 | |
| Coexpression | GSE40273_EOS_KO_VS_WT_TREG_DN | 1.42e-04 | 200 | 103 | 6 | M9130 | |
| Coexpression | GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN | 1.42e-04 | 200 | 103 | 6 | M6938 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CUL3 TPR ABCF1 ERCC5 COQ5 CHD1 CNTLN STIL REV3L BPTF IGF2BP3 CCDC88A FAM193A SETD5 ZNF644 SYNE2 ANGPTL4 NAT10 ASPM MACF1 ROCK1 CEP295 MAP3K7 TCF7L1 | 2.86e-09 | 1257 | 100 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CUL3 TPR ABCF1 ERCC5 COQ5 CHD1 CNTLN STIL REV3L BPTF IGF2BP3 CCDC88A FAM193A SETD5 ZNF644 SYNE2 ANGPTL4 NAT10 ASPM MACF1 ROCK1 CEP295 MAP3K7 TCF7L1 | 5.06e-08 | 1459 | 100 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | ABCF1 ZYG11B ZNF226 REV3L MAST2 RCOR1 CCDC88A FAM193A ZNF644 CEP250 SYNE2 MACF1 ROCK1 POLK MAP3K7 GOLGA3 | 7.12e-07 | 780 | 100 | 16 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | TPR ANGPT1 SYNE1 ZYG11B CNTLN REV3L RCOR1 ZFHX4 MACF1 ROCK1 CEP295 GOLGB1 | 9.01e-07 | 432 | 100 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.45e-06 | 298 | 100 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.61e-06 | 369 | 100 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | TPR SYNE1 CNTLN STIL REV3L CCDC88A ZFHX4 ZNF644 NRK ANGPTL4 CLTB MACF1 ROCK1 | 4.64e-05 | 744 | 100 | 13 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | TPR ANGPT1 SYNE1 ZYG11B ZNF226 CNTLN REV3L RCOR1 ZFHX4 SYNE2 MACF1 ROCK1 CEP295 GOLGB1 JHY | 5.88e-05 | 989 | 100 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.58e-05 | 385 | 100 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | TPR MYH11 ANGPT1 LAMA3 CHD1 REV3L GATAD2B FAM193A ZFHX4 SETD5 NRK ASPM MAP3K7 | 1.04e-04 | 806 | 100 | 13 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.12e-04 | 311 | 100 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.15e-04 | 312 | 100 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TPR ABCF1 CHD1 CNTLN STIL CCDC88A SETD5 ZNF644 SYNE2 NAT10 SSX2IP ASPM MACF1 CEP295 TCF7L1 | 1.27e-04 | 1060 | 100 | 15 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ABCF1 PNRC2 CHD1 MAST2 CCDC88A FAM193A ATP8A1 CEP250 SYNE2 ASPM CEP295 MAP3K7 GOLGA3 | 1.41e-04 | 831 | 100 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ABCF1 CHD1 REV3L IGF2BP3 CCDC88A FAM193A ATP8A1 SYNE2 NAT10 ASPM ROCK1 CEP295 JHY PCNT | 2.18e-04 | 989 | 100 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | CUL3 TPR ANGPT1 CHD1 CNTLN STIL REV3L CCDC88A SETD5 ZNF644 SYNE2 NAT10 ASPM ROCK1 CEP295 MAP3K7 | 2.39e-04 | 1252 | 100 | 16 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 3.15e-04 | 194 | 100 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.96e-11 | 200 | 103 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.36e-08 | 188 | 103 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.20e-08 | 200 | 103 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.43e-07 | 184 | 103 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-07 | 186 | 103 | 7 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-07 | 186 | 103 | 7 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.72e-07 | 196 | 103 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.72e-07 | 196 | 103 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.99e-07 | 198 | 103 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.12e-07 | 199 | 103 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 4.12e-07 | 199 | 103 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.12e-07 | 199 | 103 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 4.12e-07 | 199 | 103 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.91e-06 | 171 | 103 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.79e-06 | 179 | 103 | 6 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-06 | 182 | 103 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-06 | 184 | 103 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-06 | 185 | 103 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-06 | 186 | 103 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-06 | 188 | 103 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-06 | 191 | 103 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | 5.50e-06 | 191 | 103 | 6 | 37cf121e6e80760c8519075b7845b9029958a988 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-06 | 191 | 103 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.01e-06 | 194 | 103 | 6 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.56e-06 | 197 | 103 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.75e-06 | 198 | 103 | 6 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 6.95e-06 | 199 | 103 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 6.95e-06 | 199 | 103 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.95e-06 | 199 | 103 | 6 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-06 | 199 | 103 | 6 | 78a9b26215874a46a910a4b93a51fcac1a597618 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 9.18e-06 | 121 | 103 | 5 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 125 | 103 | 5 | 35042ed43045dddc341b76cc5f9fe31b5ba0abb8 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.56e-05 | 135 | 103 | 5 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-05 | 136 | 103 | 5 | a43b3db1754c619d328a26a2ba6af4756629a723 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.23e-05 | 157 | 103 | 5 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.75e-05 | 162 | 103 | 5 | 19395bdb282b4a2d88cd33191af12c24a88c3d16 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 4.85e-05 | 171 | 103 | 5 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 4.85e-05 | 171 | 103 | 5 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.12e-05 | 173 | 103 | 5 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.41e-05 | 175 | 103 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 5.56e-05 | 176 | 103 | 5 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 176 | 103 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.71e-05 | 177 | 103 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.02e-05 | 179 | 103 | 5 | 948c2a01ec7a626c68281e6e796a9f0527a88591 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.18e-05 | 180 | 103 | 5 | 5c9d2d44d840cd4ec7d42d43446ba2b689e7ec43 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.18e-05 | 180 | 103 | 5 | c60e74fbbd815a0251253a19dc520a254b2e1762 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.34e-05 | 181 | 103 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.68e-05 | 183 | 103 | 5 | 807d64deaf4e50dccf6f831f88578a6d903c1421 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-05 | 183 | 103 | 5 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-05 | 183 | 103 | 5 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 184 | 103 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 184 | 103 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 184 | 103 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.86e-05 | 184 | 103 | 5 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-05 | 185 | 103 | 5 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-05 | 185 | 103 | 5 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-05 | 185 | 103 | 5 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 187 | 103 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.40e-05 | 187 | 103 | 5 | 46e15419e80bd7180f3171a99d845b01bb635e53 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.40e-05 | 187 | 103 | 5 | 0d17b07770e4c881a7ca53a5bd42471457d198fb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.40e-05 | 187 | 103 | 5 | 69068480f6819a6c8560ecbb05deb156b4055e12 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.40e-05 | 187 | 103 | 5 | 9c8b932a15b8b50982cba4cf8db750e257eb9503 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-05 | 187 | 103 | 5 | 9225caf66e06ebe57e90d677122acb6498607f36 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 7.59e-05 | 188 | 103 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 188 | 103 | 5 | 40ce7125fca6f6b6b5cc1637c87d43c29b08f4f1 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 7.59e-05 | 188 | 103 | 5 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 188 | 103 | 5 | ba7f7ce034c0f42742bf2461f68f8d343ee593a5 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.78e-05 | 189 | 103 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.98e-05 | 190 | 103 | 5 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.98e-05 | 190 | 103 | 5 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.98e-05 | 190 | 103 | 5 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.98e-05 | 190 | 103 | 5 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.98e-05 | 190 | 103 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.98e-05 | 190 | 103 | 5 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.98e-05 | 190 | 103 | 5 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 191 | 103 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 8.38e-05 | 192 | 103 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.59e-05 | 193 | 103 | 5 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.80e-05 | 194 | 103 | 5 | f15e81ff12525523c62d13105cf264ea72205e2e | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.80e-05 | 194 | 103 | 5 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.80e-05 | 194 | 103 | 5 | f2f7b9aad7588c8020a4850ff9333e1db8eafac7 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.01e-05 | 195 | 103 | 5 | 598b69032a8441a23749b27863d80f7a1fc82a96 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.01e-05 | 195 | 103 | 5 | 8aa753934debffe5ae4b5eecb6b50c46d17cc3ec | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.23e-05 | 196 | 103 | 5 | f78951b460913866d092ba92af70ea76a2afa73e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.23e-05 | 196 | 103 | 5 | 01cea0bb0b938d0986fd2ddae06597b8af1768ee | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.23e-05 | 196 | 103 | 5 | 69ad90a429af4dad5a45556544224001ebcb1607 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.23e-05 | 196 | 103 | 5 | 4da96672a9c72268cfcc82d61eb3caae6e02d4c4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.23e-05 | 196 | 103 | 5 | a2db88fad9bbc55685f8e681d120ef38715ca3c4 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.46e-05 | 197 | 103 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.46e-05 | 197 | 103 | 5 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.46e-05 | 197 | 103 | 5 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.46e-05 | 197 | 103 | 5 | da653dc7d216e202f390e5ab0245f243e3ed213b | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 9.69e-05 | 198 | 103 | 5 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.69e-05 | 198 | 103 | 5 | d5990cab01de6e6f3757f5a50ef70ced711bb1fa | |
| ToppCell | distal-2-mesenchymal-Vascular_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.69e-05 | 198 | 103 | 5 | ce05ede69c167b2294630709bb0c223483a6ef75 | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 9.92e-05 | 199 | 103 | 5 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 9.92e-05 | 199 | 103 | 5 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.29e-07 | 49 | 67 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.38e-05 | 50 | 67 | 5 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.38e-05 | 50 | 67 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.56e-04 | 50 | 67 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 2.28e-06 | 190 | 102 | 8 | 2700_UP | |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; PC3; HT_HG-U133A | 2.98e-06 | 197 | 102 | 8 | 4622_UP | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; MCF7; HT_HG-U133A | 3.10e-06 | 198 | 102 | 8 | 5469_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.21e-05 | 171 | 102 | 7 | 7535_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.16e-05 | 187 | 102 | 7 | 4989_DN | |
| Drug | benzylpiperazine | 2.42e-05 | 13 | 102 | 3 | CID000075994 | |
| Drug | 8-oxyguanine | 2.65e-05 | 130 | 102 | 6 | CID000119315 | |
| Drug | Indoprofen [31842-01-0]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.73e-05 | 194 | 102 | 7 | 3345_UP | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; HL60; HT_HG-U133A | 2.82e-05 | 195 | 102 | 7 | 2568_DN | |
| Drug | Metolazone [17560-51-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.82e-05 | 195 | 102 | 7 | 5392_UP | |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 2.82e-05 | 195 | 102 | 7 | 4738_UP | |
| Drug | Hexestrol [84-16-2]; Up 200; 14.8uM; HL60; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 2515_UP | |
| Drug | Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; PC3; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 5812_DN | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 7057_DN | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 3567_DN | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; PC3; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 6745_DN | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 3447_UP | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; PC3; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 6727_DN | |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; HL60; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 3042_DN | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 5766_DN | |
| Drug | DNA-PK Inhibitor III; Down 200; 1uM; MCF7; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 7543_DN | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 6226_UP | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 4964_UP | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.21e-05 | 199 | 102 | 7 | 6444_UP | |
| Drug | plakin | 3.39e-05 | 82 | 102 | 5 | CID000018752 | |
| Drug | geldanamycin | 4.44e-05 | 371 | 102 | 9 | ctd:C001277 | |
| Drug | 3-sulfanylhexyl acetate | 5.94e-05 | 3 | 102 | 2 | CID000518810 | |
| Drug | thymine | 8.73e-05 | 315 | 102 | 8 | CID000001135 | |
| Disease | triglycerides in LDL measurement | 3.98e-05 | 56 | 100 | 4 | EFO_0022320 | |
| Disease | mean platelet volume | MYH11 SPTA1 SDCCAG8 SPTBN1 ITGA2B STIL TFAP4 PWWP2A RCOR1 TMCC2 SYNE2 DSE PLCE1 | 4.11e-05 | 1020 | 100 | 13 | EFO_0004584 |
| Disease | platelet component distribution width | ANGPT1 BMP2K SYNE1 SPTA1 SDCCAG8 ITGA2B PWWP2A TMCC2 MACF1 POLK TCF7L1 | 5.13e-05 | 755 | 100 | 11 | EFO_0007984 |
| Disease | cholesterol to total lipids in IDL percentage | 5.23e-05 | 60 | 100 | 4 | EFO_0022233 | |
| Disease | C-reactive protein measurement | RAB35 COQ5 APOB CCDC168 ZNF226 CREB3L1 GATAD2B BPTF IGF2BP3 SETD5 ZNF644 TMCC2 MACF1 TBL2 | 5.60e-05 | 1206 | 100 | 14 | EFO_0004458 |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 6.79e-05 | 4 | 100 | 2 | cv:CN293514 | |
| Disease | hearing loss | 8.08e-05 | 67 | 100 | 4 | EFO_0004238 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 1.13e-04 | 5 | 100 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 1.13e-04 | 5 | 100 | 2 | C0410190 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.19e-04 | 74 | 100 | 4 | EFO_0022280 | |
| Disease | Emery-Dreifuss muscular dystrophy | 1.69e-04 | 6 | 100 | 2 | cv:C0410189 | |
| Disease | stearoyl sphingomyelin (d18:1/18:0) measurement | 1.69e-04 | 6 | 100 | 2 | EFO_0800611 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.69e-04 | 6 | 100 | 2 | C0410189 | |
| Disease | Thyroid Gland Follicular Adenoma | 2.28e-04 | 35 | 100 | 3 | C0151468 | |
| Disease | response to tamsulosin | 2.36e-04 | 7 | 100 | 2 | GO_1901905 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 2.36e-04 | 7 | 100 | 2 | C0751337 | |
| Disease | Thyroid Neoplasm | 2.70e-04 | 37 | 100 | 3 | C0040136 | |
| Disease | calcium measurement | 2.88e-04 | 628 | 100 | 9 | EFO_0004838 | |
| Disease | nephronophthisis (implicated_via_orthology) | 4.03e-04 | 9 | 100 | 2 | DOID:12712 (implicated_via_orthology) | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 4.25e-04 | 103 | 100 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | Thyroid carcinoma | 4.52e-04 | 44 | 100 | 3 | C0549473 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 5.63e-04 | 111 | 100 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | brain measurement, neuroimaging measurement | 5.75e-04 | 550 | 100 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 6.13e-04 | 11 | 100 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | obsolete_red blood cell distribution width | CUL3 BMP2K SPTA1 APOB RCOR1 TMCC2 SYNE2 ANGPTL4 POLK TBL2 EP300 MAST3 BBOF1 | 6.25e-04 | 1347 | 100 | 13 | EFO_0005192 |
| Disease | cholesteryl esters to total lipids in IDL percentage | 6.59e-04 | 50 | 100 | 3 | EFO_0022247 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 7.34e-04 | 12 | 100 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 7.79e-04 | 121 | 100 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | Diffuse Large B-Cell Lymphoma | 8.72e-04 | 55 | 100 | 3 | C0079744 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 9.33e-04 | 127 | 100 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.01e-03 | 224 | 100 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | low density lipoprotein particle size measurement | 1.02e-03 | 58 | 100 | 3 | EFO_0008593 | |
| Disease | Autosomal recessive primary microcephaly | 1.16e-03 | 15 | 100 | 2 | cv:C3711387 | |
| Disease | Hypertriglyceridemia | 1.16e-03 | 15 | 100 | 2 | C0020557 | |
| Disease | triglycerides in small VLDL measurement | 1.18e-03 | 61 | 100 | 3 | EFO_0022145 | |
| Disease | triglycerides in small HDL measurement | 1.24e-03 | 62 | 100 | 3 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 1.24e-03 | 62 | 100 | 3 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 1.24e-03 | 62 | 100 | 3 | EFO_0022322 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 1.24e-03 | 62 | 100 | 3 | EFO_0022339 | |
| Disease | T-Cell Lymphoma | 1.32e-03 | 16 | 100 | 2 | C0079772 | |
| Disease | Bladder Neoplasm | 1.34e-03 | 140 | 100 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.37e-03 | 141 | 100 | 4 | C0005684 | |
| Disease | cortical thickness | ANGPT1 SPTBN1 MAST2 TFAP4 GATAD2B PHLDB1 CCDC88A SETD5 MACF1 MAP3K7 PLCE1 | 1.38e-03 | 1113 | 100 | 11 | EFO_0004840 |
| Disease | triglycerides in small LDL measurement | 1.42e-03 | 65 | 100 | 3 | EFO_0022323 | |
| Disease | breast carcinoma (is_marker_for) | 1.48e-03 | 66 | 100 | 3 | DOID:3459 (is_marker_for) | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.48e-03 | 144 | 100 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | platelet-to-lymphocyte ratio | 1.50e-03 | 363 | 100 | 6 | EFO_0008446 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.55e-03 | 67 | 100 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | mean reticulocyte volume | 1.59e-03 | 799 | 100 | 9 | EFO_0010701 | |
| Disease | triglycerides in very small VLDL measurement | 1.61e-03 | 68 | 100 | 3 | EFO_0022144 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.72e-03 | 150 | 100 | 4 | EFO_0004611, EFO_0020947 | |
| Disease | hemoglobin A1 measurement | 1.98e-03 | 520 | 100 | 7 | EFO_0007629 | |
| Disease | prostate cancer (is_marker_for) | 1.99e-03 | 156 | 100 | 4 | DOID:10283 (is_marker_for) | |
| Disease | Osteogenesis imperfecta | 2.29e-03 | 21 | 100 | 2 | cv:C0029434 | |
| Disease | preeclampsia | 2.39e-03 | 78 | 100 | 3 | EFO_0000668 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.49e-03 | 166 | 100 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | Autosomal Recessive Primary Microcephaly | 2.51e-03 | 22 | 100 | 2 | C3711387 | |
| Disease | Primary microcephaly | 2.51e-03 | 22 | 100 | 2 | C0431350 | |
| Disease | sphingomyelin measurement | 2.60e-03 | 278 | 100 | 5 | EFO_0010118 | |
| Disease | reticulocyte count | ANGPT1 BMP2K SPTA1 LAMA3 SPATA20 MAST2 RCOR1 TMCC2 SYNE2 ANGPTL4 | 2.89e-03 | 1045 | 100 | 10 | EFO_0007986 |
| Disease | non-high density lipoprotein cholesterol measurement | 2.96e-03 | 713 | 100 | 8 | EFO_0005689 | |
| Disease | Dyslipidemias | 2.99e-03 | 24 | 100 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 2.99e-03 | 24 | 100 | 2 | C0598784 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.17e-03 | 291 | 100 | 5 | EFO_0008317, EFO_0020946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKLQNASKQIVQNAI | 16 | P0CW23 | |
| ASKQIVQNAILQAVQ | 21 | P0CW23 | |
| CLNIKQKLRQQQLQH | 1806 | Q09472 | |
| QQQQQQQQKKKRDTR | 66 | Q8NE71 | |
| NANRTLLQQLQKLQT | 341 | Q96BA8 | |
| QTQLKAQNSRIQQLF | 106 | Q9BY76 | |
| LQQQNSVLQNAKKTA | 991 | Q9NXG0 | |
| MIKTQQQLLQQQLAT | 396 | Q9Y2D8 | |
| QLNRATTNNSVLQKQ | 236 | Q15389 | |
| QQQTILKIKNKAQRV | 3126 | Q96M86 | |
| QQQKVKQRSLQKLSS | 966 | Q9NSY1 | |
| QLQRVQQLRDQQQKK | 2626 | Q12830 | |
| MQLVQQRSQIQTLQK | 276 | Q8ND07 | |
| QRSQIQTLQKKVVNL | 281 | Q8ND07 | |
| VQRSAILKKQQQQQQ | 96 | O14646 | |
| IKVNSETQQQLNKIN | 1116 | Q14004 | |
| KVNSNNNNKKQLNHI | 1101 | P78312 | |
| QVNQRKNFLQVKKAA | 1791 | Q8IZT6 | |
| ADNAVNKKQTQVLRN | 126 | Q9Y2Q0 | |
| KNQITNNQRIKASIP | 31 | P07205 | |
| VSVKRQIQNIKQTNS | 346 | Q9UKL0 | |
| SLKRQVQNAKQVNSA | 251 | Q9P2K3 | |
| QQQQNDVVKLTKNSK | 181 | Q15286 | |
| KLKQASQKSQRAQQV | 316 | Q9Y250 | |
| RRAKQKASQQRQQQQ | 961 | O75420 | |
| QEKAQVNSRKAQTLN | 1906 | Q16787 | |
| RQQQNQNKPLDTSTK | 396 | Q6NUN7 | |
| VTNLLTRNQDKQRQK | 386 | Q0VAK6 | |
| SSRIQKLLQDNQRQK | 336 | Q6UWE0 | |
| TDKGQQLRKNQQLQR | 691 | Q13144 | |
| QRLQKTLENSNKKIQ | 766 | Q3V6T2 | |
| KTQLKQLETQNNNLQ | 1066 | Q3V6T2 | |
| NVNVVKRLFKIQNLN | 231 | Q969U6 | |
| QQQKVVNKLIQFLIS | 181 | Q00613 | |
| IQNNKQVLRNLINSS | 1806 | A6NKB5 | |
| NVSKNQQQLNRQKTK | 16 | Q9NPJ4 | |
| QQCKKQLEVIRSQQQ | 586 | O43318 | |
| KNIRQSKQQKITQAI | 186 | Q9NX36 | |
| IQRLQSQTENLKKQN | 336 | Q8N1N4 | |
| ISQQQQQQSKSKKNR | 796 | Q9UL01 | |
| LRQSQLQKENVVQKT | 186 | Q8WXI9 | |
| LKNNMKTLLQQNQQL | 1356 | Q08378 | |
| LSLQLQKKNHQVQQL | 1091 | O95613 | |
| ILTQVKQHQQQKALQ | 556 | O00425 | |
| KLIQQLRQQSAQSQV | 426 | Q9H0A0 | |
| NTLNKKVAQRIAQLQ | 5326 | Q9UPN3 | |
| NQLAKVTNKQRREQQ | 336 | Q5T2D3 | |
| LQQKINNSSNKIQVR | 376 | Q3MIT2 | |
| LNKQNIINQAITAKN | 561 | Q9HDB9 | |
| NKINSKHLRVNQNLV | 2961 | P04114 | |
| KTNQLNLQNTATKAI | 71 | Q05707 | |
| LLKNAIQEIQRKNNS | 36 | Q13618 | |
| KLKNSQEAQQRQATL | 41 | Q9BV73 | |
| SQQQSRIQQQEALLK | 436 | Q5VVM6 | |
| IQFLKRTNQQLKAQL | 236 | O14645 | |
| KKINKQNLILRNQIQ | 541 | Q6P0Q8 | |
| KKINKQNLILRNQIQ | 396 | O60307 | |
| NYVQSQHQRKQKRQL | 126 | Q5HYK3 | |
| QHQRKQKRQLRAQQN | 131 | Q5HYK3 | |
| NAKQSIQLQKLFQRN | 6046 | Q8NDH2 | |
| QQQQKQATYRERNKT | 996 | Q9Y613 | |
| QQQKVKQRSLQKLSS | 216 | Q5H9B9 | |
| QALQQQLDTQKKAIR | 1506 | Q9C0D2 | |
| QRQVNQESLKLLNKL | 31 | Q86WN2 | |
| NTQQKLQKSEQSVAQ | 126 | Q07866 | |
| NQLVQKAILQKNKSA | 1426 | Q13029 | |
| LQVQSQVSKKQQAQT | 491 | Q7Z2Y5 | |
| QNESQKRNAVVKVSN | 376 | Q96N64 | |
| VKNNTQVLINCRNNK | 36 | P62316 | |
| ANNADKQQVSRIKQV | 321 | O75069 | |
| QQQKILQQSRIVQSQ | 156 | Q8IZU3 | |
| SAKKRDVQQQIAQAQ | 1286 | Q8NF91 | |
| SLQQQQQHLQLRLKS | 2641 | Q8WXH0 | |
| TKAKQLLQQILTNEQ | 2036 | Q9P212 | |
| QATAQQLVQLLSKQN | 671 | Q86SQ7 | |
| SNLLAQQNSLKAQKQ | 741 | P28715 | |
| QQNSLKAQKQQQERI | 746 | P28715 | |
| VNKANINFLRKLVQN | 396 | O14802 | |
| SAQRLKRQKQANAQQ | 626 | Q9C0A6 | |
| QLQIRSKNSQNPNSK | 751 | P08514 | |
| QVRLLTPQKQSNSNQ | 351 | Q8N1H7 | |
| NLQTVQLLIKKNQTL | 1516 | Q01082 | |
| QRQSEQVEKNKINNR | 141 | P09497 | |
| QKNESARQQLERQNK | 1781 | P35749 | |
| SQVISQLKQKLENLQ | 761 | P48736 | |
| RNITNEVLQTKAKQQ | 1196 | Q15468 | |
| KQKNQRNLNRETNII | 151 | I1YAP6 | |
| QQQQASKLLKQEQSN | 1781 | Q86UP3 | |
| QLLQIVKQKTNQNSV | 496 | Q9C0D3 | |
| KQQRTNNENIKRTLS | 1061 | O60673 | |
| KREKQLSQTQSQQQV | 426 | Q9HCS4 | |
| NQKLTATTQKQEQII | 746 | P12270 | |
| QKCQQQQQKRQRLKE | 266 | Q8N0S2 | |
| KQNKNTLLENSQRVT | 206 | Q8TB22 | |
| ATQRIVQDKLKQLNQ | 26 | O14787 | |
| KAQITSQQLRKAQLQ | 71 | Q9UBT6 | |
| KAQQQIRQTLKQQET | 66 | O75830 | |
| KDIQNLKSRVQKQQV | 611 | P02549 | |
| TKRQLALQQKGQQVI | 1031 | Q86UU1 | |
| QNSQLANEKLSQLQK | 531 | Q13464 | |
| ILKRNLENTQNQIKA | 906 | Q9BZF9 | |
| SQRLNRDQQISIKNK | 181 | Q9NYT6 | |
| QQDVNKTKSRLNVLN | 6 | Q9H582 | |
| QEKTRLLQQNTQLKR | 101 | Q01664 | |
| QRLQQQLTQAQETLK | 426 | Q9Y4P3 | |
| TTQQQQQQKLRLQRI | 226 | Q9GZV5 | |
| NQVITIKDSQQKQLL | 2541 | Q14789 | |
| KVRFLEQQNQVLQTK | 181 | Q7Z794 | |
| QSKIQKQLDQVRKQQ | 3571 | O14686 | |
| QNANKVIQNLKSRVR | 1366 | Q5VU43 |